These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 39085973)

  • 1. Understanding machine learning applications in dementia research and clinical practice: a review for biomedical scientists and clinicians.
    Wang Y; Liu S; Spiteri AG; Huynh ALH; Chu C; Masters CL; Goudey B; Pan Y; Jin L
    Alzheimers Res Ther; 2024 Aug; 16(1):175. PubMed ID: 39085973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten years of image analysis and machine learning competitions in dementia.
    Bron EE; Klein S; Reinke A; Papma JM; Maier-Hein L; Alexander DC; Oxtoby NP
    Neuroimage; 2022 Jun; 253():119083. PubMed ID: 35278709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction.
    Spooner A; Chen E; Sowmya A; Sachdev P; Kochan NA; Trollor J; Brodaty H
    Sci Rep; 2020 Nov; 10(1):20410. PubMed ID: 33230128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review.
    Grueso S; Viejo-Sobera R
    Alzheimers Res Ther; 2021 Sep; 13(1):162. PubMed ID: 34583745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.
    Gill S; Mouches P; Hu S; Rajashekar D; MacMaster FP; Smith EE; Forkert ND; Ismail Z;
    J Alzheimers Dis; 2020; 75(1):277-288. PubMed ID: 32250302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
    Ma D; Yee E; Stocks JK; Jenkins LM; Popuri K; Chausse G; Wang L; Probst S; Beg MF
    J Alzheimers Dis; 2021; 80(2):715-726. PubMed ID: 33579858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on machine and statistical learning for longitudinal analysis of neuroimaging data in Alzheimer's disease.
    Martí-Juan G; Sanroma-Guell G; Piella G
    Comput Methods Programs Biomed; 2020 Jun; 189():105348. PubMed ID: 31995745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
    Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE
    PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
    Ding H; Mandapati A; Hamel AP; Karjadi C; Ang TFA; Xia W; Au R; Lin H
    J Alzheimers Dis; 2023; 96(1):277-286. PubMed ID: 37742648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects.
    Ahmed MR; Zhang Y; Feng Z; Lo B; Inan OT; Liao H
    IEEE Rev Biomed Eng; 2019; 12():19-33. PubMed ID: 30561351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.
    Blanco K; Salcidua S; Orellana P; Sauma-Pérez T; León T; Steinmetz LCL; Ibañez A; Duran-Aniotz C; de la Cruz R
    Alzheimers Res Ther; 2023 Oct; 15(1):176. PubMed ID: 37838690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis.
    Li X; Qiu Y; Zhou J; Xie Z
    Curr Genomics; 2021 Dec; 22(8):564-582. PubMed ID: 35386189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the Power of Machine Learning in Dementia Informatics Research: Issues, Opportunities, and Challenges.
    Tsang G; Xie X; Zhou SM
    IEEE Rev Biomed Eng; 2020; 13():113-129. PubMed ID: 30872241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretable machine learning for dementia: A systematic review.
    Martin SA; Townend FJ; Barkhof F; Cole JH
    Alzheimers Dement; 2023 May; 19(5):2135-2149. PubMed ID: 36735865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia.
    Tam A; Dansereau C; Iturria-Medina Y; Urchs S; Orban P; Sharmarke H; Breitner J; Bellec P;
    Gigascience; 2019 May; 8(5):. PubMed ID: 31077314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
    Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
    Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
    Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
    Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of profiles associated with conversions between the Alzheimer's disease stages, using a machine learning approach.
    Dauphinot V; Laurent M; Prodel M; Civet A; Vainchtock A; Moutet C; Krolak-Salmon P; Garnier-Crussard A
    Alzheimers Res Ther; 2024 Jul; 16(1):166. PubMed ID: 39061107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.